Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Investing in the life science sector

Analyst Interviews

Life science analyst Antti Siltanen reveals some truths about investing in life science companies. Learn about the biggest misconceptions about life science companies, what to consider when evaluating the potential of a new drug, and the trends shaping the life sciences landscape in the next 5-10 years. Antti also provides some advice for investors looking to get started in life science investing.

Recent videos

Nordic Bloom - Live fra Silicon Valley: Mød Jared Heyman fra Rebel Fondene
10.03.2026, 15.00
Gubra – Presentation of Phase 1 Topline Results on ABBV-295 long-acting amylin analog
10.03.2026, 13.30 Gubra
Hanza, Capital Markets Day, CMD, 2026
10.03.2026, 13.00 HANZA
HCA Morgenbørs 09/03 - Et store fald på futures fronten, oliepriser har krydset 100 og øget nervøsitet omkring finansiering af AI udbygningen
10.03.2026, 09.26 Torm
HCA Morgenbørs 10/03 - Europæiske futures indikerer et re-bound
10.03.2026, 09.15 Rockwool
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.